Microcapsules are produced continuously under controlled, sterile conditions.
The pulse-flow microencapsulation system (PFMS) is an automated system that continuously produces a stream of liquid-filled microcapsules for delivery of therapeutic agents to target tissues. Prior microencapsulation systems have relied on batch processes that involve transfer of batches between different apparatuses for different stages of production followed by sampling for acquisition of quality-control data, including measurements of size. In contrast, the PFMS is a single, microprocessor- controlled system that performs all processing steps, including acquisition of quality-control data. The quality-control data can be used as real-time feedback to ensure the production of large quantities of uniform microcapsules.
The PFMS (see figure) contains pumps, valves, and ultrasonic nozzles, all operated in coordination to produce multilamellar microcapsules in a continuous stream. The PFMS comprises five major subsystems:
- A pulse-flow, dual-nozzle microcapsule dispenser.
- A sterile treatment flow module into which the liquid microcapsules are dropped to form their outer polymer walls.
- A fluidized bed for washing and harvesting the microcapsules produced by the combination of subsystems 1 and 2.
- A microcapsule flow sensor, which acquires images of the microcapsules for quality control.
- A microprocessor control module, which controls the operation of the pulse-flow microcapsule dispenser and the microcapsule flow sensor; logs the outputs of all sensors, including the microcapsule flow sensor; processes output of the microcapsule flow sensor to measure the sizes of the microcapsules, count the microcapsules, and distinguish between microcapsules and debris particles, which can be of about the same size; and effects feedback control of all pumps, ultrasonic transducers, and valves.
This work was done by Dennis R. Morrison of Johnson Space Center. This invention is owned by NASA, and a patent application has been filed. Inquiries concerning nonexclusive or exclusive license for its commercial development should be addressed to the Patent Counsel, Johnson Space Center, (281) 483-0837. Refer to MSC-23659.